Genetics of coagulation factors in acute lung injury

被引:34
作者
Russell, JA
机构
[1] St Pauls Hosp, Dept Med, Div Crit Care Med, Vancouver, BC V6Z 1Y6, Canada
[2] St Pauls Hosp, UBC McDonald Res Lab, Vancouver, BC V6Z 1Y6, Canada
关键词
alpha-thrombin; fibrin; fibrinogen; protein C; factor V; endothelial protein C receptor; interleukin-1; interieukin-6; interleukin-8; plasminogen activator inhibitor-1; single nucleotide polymorphisms; tumor necrosis factor-alpha;
D O I
10.1097/01.CCM.0000057870.61079.3E
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objectives. To review the role of coagulation and of single nucleotide polymorphisms of coagulation factors in acute lung injury. Data Sources and Study Selection., MEDLINE search of selected basic and clinical studies in English literature. Conclusions: Exuberant coagulation relative to anticoagulation and fibrinolysis in the lung and the systemic circulation are important in the pathophysiology of acute lung injury. In the early stages of acute lung injury, fibrin is deposited in the alveoli, and fibrin in the alveoli increases the inflammatory response. Sepsis, trauma, and aspiration are risk factors for acute lung injury. They are also-potent stimuli for increased coagulation because inflammatory stimuli activate coagulation and proinflammatory cascades. There is "cross-talk" amplification of the coagulation and inflammatory cascades. Inflammatory mediators activate coagulation. Tumor necrosis factor-alpha, interleukin-1, and interleukin-6 increase tissue factor and inhibit fibrinolysis, thereby activating the extrinsic pathway. Conversely, intravascular coagulation induces an inflammatory response. Coagulation of blood in vitro increases the production of tumor necrosis factor-alpha, interleukin-1, and interleukin-8 by monocytes. Factor Xa, alpha-thrombin, and fibrin increase synthesis of interleukin-6 and interleukin-8. Genetic predisposition could increase the tendency to intravascular and intraalveolar coagulation. Single nucleotide polymorphisms and single nucleotide polymorphism haplotypes of coagulation factor genes increase coagulation and impair anticoagulation and fibrinolysis, which could tip the balance in favor of coagulation. For example, procoagulant and antifibrinolytic single nucleotide polymorphisms in the promoter and coding regions have been reported for alpha-thrombin, fibrinogen, factor V, protein C, endothelial protein C receptor, and plasminogen activator inhibitor-1. Single nucleotide polymorphisms of protein C, factor V (e.g., factor V Leiden), and plasminogen, activator inhibitor-1 are associated with an increased risk of deep venous thrombosis, pulmonary emboli, acute myocardial infarction, and stroke. These and other single nucleotide polymorphisms could be associated with increased risk of coagulation relative to anticoagulation/fibrinolysis in the vascular spaces and airspaces of the lung, thus increasing the risk of acute lung injury in patients with sepsis, trauma, aspiration, and other precursors of acute lung injury.
引用
收藏
页码:S243 / S247
页数:5
相关论文
共 24 条
[1]   Complex association of protein C gene promoter polymorphism with circulating protein C levels and thrombotic risk [J].
Aiach, M ;
Nicaud, V ;
Alhenc-Gelas, M ;
Gandrille, S ;
Arnaud, E ;
Amiral, J ;
Guize, L ;
Fiessinger, JN ;
Emmerich, J .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (06) :1573-1576
[2]   Efficacy and safety of recombinant human activated protein C for severe sepsis. [J].
Bernard, GR ;
Vincent, JL ;
Laterre, P ;
LaRosa, SP ;
Dhainaut, JF ;
Lopez-Rodriguez, A ;
Steingrub, JS ;
Garber, GE ;
Helterbrand, JD ;
Ely, EW ;
Fisher, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :699-709
[3]   DEPRESSED BRONCHOALVEOLAR UROKINASE ACTIVITY IN PATIENTS WITH ADULT RESPIRATORY-DISTRESS SYNDROME [J].
BERTOZZI, P ;
ASTEDT, B ;
ZENZIUS, L ;
LYNCH, K ;
LEMAIRE, F ;
ZAPOL, W ;
CHAPMAN, HA .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (13) :890-897
[4]   Genetic variation in coagulation and fibrinolytic proteins and their relation with acute myocardial infarction [J].
Boekholdt, SM ;
Bijsterveld, NR ;
Moons, AHM ;
Levi, M ;
Büller, HR ;
Peters, RJG .
CIRCULATION, 2001, 104 (25) :3063-3068
[5]   EFFECTS OF FIBRINOGEN DEGRADATION FRAGMENT-D AND FRAGMENT-E ON CELL-MEDIATED-IMMUNITY [J].
FERRARA, JJ ;
KAN, C ;
LUTERMAN, A ;
CURRERI, PW .
JOURNAL OF SURGICAL RESEARCH, 1989, 47 (02) :134-137
[6]   4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease [J].
Hermans, PWM ;
Hibberd, ML ;
Booy, R ;
Daramola, O ;
Hazelzet, JA ;
de Groot, R ;
Levin, M .
LANCET, 1999, 354 (9178) :556-560
[7]  
HOLMES C, IN PRESS CHEST
[8]   Genes encoding fibrinogen and cardiovascular risk [J].
Iacoviello, L ;
Vischetti, M ;
Zito, F ;
Donati, MB .
HYPERTENSION, 2001, 38 (05) :1199-1203
[9]   LOCAL ABNORMALITIES IN COAGULATION AND FIBRINOLYTIC PATHWAYS PREDISPOSE TO ALVEOLAR FIBRIN DEPOSITION IN THE ADULT RESPIRATORY-DISTRESS SYNDROME [J].
IDELL, S ;
JAMES, KK ;
LEVIN, EG ;
SCHWARTZ, BS ;
MANCHANDA, N ;
MAUNDER, RJ ;
MARTIN, TR ;
MCLARTY, J ;
FAIR, DS .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (02) :695-705
[10]   BRONCHOALVEOLAR LAVAGE PROCOAGULANT ACTIVITY IN BLEOMYCIN-INDUCED LUNG INJURY IN MARMOSETS - CHARACTERIZATION AND RELATIONSHIP TO FIBRIN DEPOSITION AND FIBROSIS [J].
IDELL, S ;
GONZALEZ, KK ;
MACARTHUR, CK ;
GILLIES, C ;
WALSH, PN ;
MCLARTY, J ;
THRALL, RS .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1987, 136 (01) :124-133